ici 118551 has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, J; Lu, X; Luo, H; Pu, J; Xu, L; Zhang, X | 1 |
| Hu, HT; Ma, QY; Zhang, D; Zhang, M | 1 |
| Guo, K; Liu, H; Ma, Q; Shan, T; Wang, F; Wu, E; Zhang, D | 1 |
| Schuller, HM; Tithoff, P; Weddle, DL; Williams, M | 1 |
4 other study(ies) available for ici 118551 and Pancreatic Neoplasms
| Article | Year |
|---|---|
Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis.
Topics: Adrenergic beta-Antagonists; Aged; Cell Line, Tumor; Cell Movement; ELAV-Like Protein 1; Epinephrine; Epithelial-Mesenchymal Transition; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta-2; Transforming Growth Factor beta | 2017 |
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Vascular Endothelial Growth Factor A | 2010 |
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.
Topics: Adrenergic beta-2 Receptor Antagonists; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Synergism; Gemcitabine; Humans; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta-2 | 2011 |
Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Arachidonic Acid; Aspirin; Base Sequence; DNA Primers; Enzyme Inhibitors; Genes, ras; Humans; Indoles; Pancreatic Neoplasms; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2001 |